Literature DB >> 1994250

Graft-versus-host disease.

J L Ferrara1, H J Deeg.   

Abstract

Entities:  

Mesh：

Year:  1991        PMID： 1994250     DOI： 10.1056/NEJM199103073241005

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  209 in total

Review 1.  Management of graft-versus-host disease in paediatric bone marrow transplant recipients.

Authors:  M Zecca; F Locatelli
Journal:  Paediatr Drugs       Date:  2000 Jan-Feb       Impact factor: 3.022

2.  [Graft-versus-Host Disease (GvHD) - an update : Part 1: Pathophysiology, clinical features and classification of GvHD].

Authors:  R Travnik; M Beckers; D Wolff; E Holler; M Landthaler; S Karrer
Journal:  Hautarzt       Date:  2011-02       Impact factor: 0.751

Review 3.  [Histopathology of graft-versus-host disease].

Authors:  F Länger; F Puls; S Buchholz; C Loddenkemper; A Ganser; H Kreipe
Journal:  Pathologe       Date:  2011-03       Impact factor: 1.011

4.  IL-7 enhances peripheral T cell reconstitution after allogeneic hematopoietic stem cell transplantation.

Authors:  Onder Alpdogan; Stephanie J Muriglan; Jeffrey M Eng; Lucy M Willis; Andrew S Greenberg; Barry J Kappel; Marcel R M van den Brink
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

5.  [Cutaneous graft-versus-host disease].

Authors:  S Karrer
Journal:  Hautarzt       Date:  2003-05       Impact factor: 0.751

Review 6.  Immunomodulators. Future prospects.

Authors:  B C Takx-Köhlen
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

7.  Innate immune activation by the viral PAMP poly I:C potentiates pulmonary graft-versus-host disease after allogeneic hematopoietic cell transplant.

Authors:  Christine V Kinnier; Tereza Martinu; Kymberly M Gowdy; Julia L Nugent; Francine L Kelly; Scott M Palmer
Journal:  Transpl Immunol       Date:  2010-11-09       Impact factor: 1.708

8.  Genetic variation in the IL-10 pathway modulates severity of acute graft-versus-host disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor beta genotype of donor.

Authors:  Ming-Tseh Lin; Barry Storer; Paul J Martin; Li-Hui Tseng; Bryan Grogan; Pei-Jer Chen; Lue P Zhao; John A Hansen
Journal:  Blood       Date:  2005-08-18       Impact factor: 22.113

9.  The Free Radical Scavenger NecroX-7 Attenuates Acute Graft-versus-Host Disease via Reciprocal Regulation of Th1/Regulatory T Cells and Inhibition of HMGB1 Release.

Authors:  Keon-Il Im; Nayoun Kim; Jung-Yeon Lim; Young-Sun Nam; Eun-Sol Lee; Eun-Jung Kim; Hyoung Jin Kim; Soon Ha Kim; Seok-Goo Cho
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

10.  Narrowband ultraviolet B phototherapy ameliorates acute graft-versus-host disease by a mechanism involving in vivo expansion of CD4+CD25+Foxp3+ regulatory T cells.

Authors:  Satoshi Iyama; Kazuyuki Murase; Tsutomu Sato; Akari Hashimoto; Ayumi Tatekoshi; Hiroto Horiguchi; Yusuke Kamihara; Kaoru Ono; Shohei Kikuchi; Kohichi Takada; Yutaka Kawano; Tsuyoshi Hayashi; Koji Miyanishi; Yasushi Sato; Rishu Takimoto; Masayoshi Kobune; Satoru Mori; Junji Kato; Toshiharu Yamashita; Junji Kato
Journal:  Int J Hematol       Date:  2014-02-21       Impact factor: 2.490
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.